Max Robotics — Global Service Robot Directory + US Certification

About

Benjamin Darnis is a leading figure in pancreatic surgery, with a focused expertise in minimally invasive techniques and perioperative outcomes. His work critically addresses the challenges of conversion during minimally invasive left pancreatectomy (MILP), a procedure where unplanned conversion to open surgery occurs in 15–30% of cases. Darnis’s landmark 2025 study, which has already garnered 4 citations, identifies key risk factors for conversion and introduces the novel Conversion Risk Score (CRS)—a predictive tool designed to enhance preoperative planning and patient counseling. By rigorously assessing the association between conversion and severe postoperative complications, his research provides actionable insights that directly improve surgical safety and decision-making. This contribution is particularly impactful given the increasing adoption of MILP worldwide. Darnis’s work bridges a critical gap in evidence-based practice, offering surgeons a framework to mitigate risks and optimize outcomes. His ongoing investigations continue to shape the evolution of pancreatic surgery, making him a vital resource for clinicians and researchers striving to refine minimally invasive approaches and reduce patient morbidity.